英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
stetted查看 stetted 在百度字典中的解释百度英翻中〔查看〕
stetted查看 stetted 在Google字典中的解释Google英翻中〔查看〕
stetted查看 stetted 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Eikon Therapeutics
    Eikon is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines
  • Pipeline – Eikon Therapeutics
    Advancing breakthrough therapeutics through the purposeful integration of engineering and science
  • Join Us – Eikon Therapeutics
    Advancing breakthrough therapeutics through the purposeful integration of science and engineering
  • About Us – Eikon Therapeutics
    Eikon Therapeutics was founded on the premise that drug discovery could be dramatically improved through the visualization of protein motion in living cells Our founders, Robert Tjian, Luke Lavis, Xavier Darzacq and Eric Betzig believed that observing how putative drug targets respond to potential drug candidates might enable the invention of important new medicines
  • Eikon Therapeutics to Present New Phase 2 Data on EIK1001 in First-Line . . .
    MILLBRAE, Calif – October 15, 2025 – Eikon Therapeutics, Inc , a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge laboratory and in silico research to accelerate drug discovery, today announced
  • News – Eikon Therapeutics
    Advancing breakthrough therapeutics through the purposeful integration of engineering and science
  • Eikon Therapeutics Announces Business Update Highlighting Pipeline and . . .
    ‍HAYWARD, Calif – Eikon Therapeutics, Inc , which advances breakthrough therapeutics through the purposeful integration of engineering and science, announced today that it has completed the previously announced integration of TLR 7
  • Eikon Therapeutics Reports First Quarter 2026 Financial Results and . . .
    Clinical Updates Eikon continues to advance its lead programs and reports the following updates through the end of the first quarter of 2026: EIK1001 is a systemically administered dual-agonist of Toll-like receptors 7 and 8 designed to stimulate both innate and adaptive immune responses
  • Eikon Therapeutics Announces the Election of David W. Meline to its . . .
    MILLBRAE, Calif – December 2, 2025 – Eikon Therapeutics, Inc , a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge research to accelerate drug discovery, today announced the election
  • Contact Us – Eikon Therapeutics
    Advancing breakthrough therapeutics through the purposeful integration of engineering and science





中文字典-英文字典  2005-2009